Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Mirum Pharmaceuticals stock | $15.21

Learn how to easily invest in Mirum Pharmaceuticals stock.

Mirum Pharmaceuticals Inc is a biotechnology business based in the US. Mirum Pharmaceuticals shares (MIRM) are listed on the NASDAQ and all prices are listed in US Dollars. Mirum Pharmaceuticals employs 120 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Mirum Pharmaceuticals

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MIRM – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Mirum Pharmaceuticals stock price (NASDAQ: MIRM)

Use our graph to track the performance of MIRM stocks over time.

Mirum Pharmaceuticals shares at a glance

Information last updated 2021-10-17.
Latest market close$15.21
52-week range$13.85 - $26.31
50-day moving average $17.90
200-day moving average $17.12
Wall St. target price$54.57
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-5.49

Buy Mirum Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Mirum Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Mirum Pharmaceuticals price performance over time

Historical closes compared with the close of $15.21 from 2021-10-22

1 week (2021-10-15) -11.16%
1 month (2021-09-23) -24.63%
3 months (2021-07-23) -3.00%
6 months (2021-04-23) -19.18%
1 year (2020-10-23) -15.78%
2 years (2019-10-23) 94.01%
3 years (2018-10-19) N/A
5 years (2016-10-19) N/A

Mirum Pharmaceuticals financials

Revenue TTM $11 million
Gross profit TTM $0
Return on assets TTM -44.52%
Return on equity TTM -132.04%
Profit margin 0%
Book value $3.14
Market capitalisation $522.4 million

TTM: trailing 12 months

Shorting Mirum Pharmaceuticals shares

There are currently 479,159 Mirum Pharmaceuticals shares held short by investors – that's known as Mirum Pharmaceuticals's "short interest". This figure is 17.3% up from 408,378 last month.

There are a few different ways that this level of interest in shorting Mirum Pharmaceuticals shares can be evaluated.

Mirum Pharmaceuticals's "short interest ratio" (SIR)

Mirum Pharmaceuticals's "short interest ratio" (SIR) is the quantity of Mirum Pharmaceuticals shares currently shorted divided by the average quantity of Mirum Pharmaceuticals shares traded daily (recently around 307153.20512821). Mirum Pharmaceuticals's SIR currently stands at 1.56. In other words for every 100,000 Mirum Pharmaceuticals shares traded daily on the market, roughly 1560 shares are currently held short.

However Mirum Pharmaceuticals's short interest can also be evaluated against the total number of Mirum Pharmaceuticals shares, or, against the total number of tradable Mirum Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Mirum Pharmaceuticals's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Mirum Pharmaceuticals shares in existence, roughly 20 shares are currently held short) or 0.0448% of the tradable shares (for every 100,000 tradable Mirum Pharmaceuticals shares, roughly 45 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Mirum Pharmaceuticals.

Find out more about how you can short Mirum Pharmaceuticals stock.

Mirum Pharmaceuticals share dividends

We're not expecting Mirum Pharmaceuticals to pay a dividend over the next 12 months.

Mirum Pharmaceuticals share price volatility

Over the last 12 months, Mirum Pharmaceuticals's shares have ranged in value from as little as $13.85 up to $26.31. A popular way to gauge a stock's volatility is its "beta".

MIRM.US volatility(beta: 2.02)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Mirum Pharmaceuticals's is 2.0228. This would suggest that Mirum Pharmaceuticals's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Mirum Pharmaceuticals overview

Mirum Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company's lead product candidate is Maralixibat, an investigational oral drug that is in Phase 3 clinical trial for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It is also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. The company was incorporated in 2018 and is headquartered in Foster City, California. .

Frequently asked questions

What percentage of Mirum Pharmaceuticals is owned by insiders or institutions?
Currently 8.927% of Mirum Pharmaceuticals shares are held by insiders and 78.776% by institutions.
How many people work for Mirum Pharmaceuticals?
Latest data suggests 120 work at Mirum Pharmaceuticals.
When does the fiscal year end for Mirum Pharmaceuticals?
Mirum Pharmaceuticals's fiscal year ends in December.
Where is Mirum Pharmaceuticals based?
Mirum Pharmaceuticals's address is: 950 Tower Lane, Foster City, CA, United States, 94404
What is Mirum Pharmaceuticals's ISIN number?
Mirum Pharmaceuticals's international securities identification number is: US6047491013
What is Mirum Pharmaceuticals's CUSIP number?
Mirum Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 604749101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site